Morepen Laboratories Ltd (MORL)

Currency in INR
61.69
+0.15(+0.24%)
Closed·
MORL Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
MORL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
60.9862.11
52 wk Range
41.66100.80
Key Statistics
Bid/Ask
61.40 / 61.54
Prev. Close
61.54
Open
61.6
Day's Range
60.98-62.11
52 wk Range
41.66-100.8
Volume
108.21K
Average Volume (3m)
507.86K
1-Year Change
11.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MORL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Morepen Laboratories Ltd Company Profile

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Employees
2152
Market
India

Compare MORL to Peers and Sector

Metrics to compare
MORL
Peers
Sector
Relationship
P/E Ratio
28.5x34.3x−0.5x
PEG Ratio
1.680.810.00
Price/Book
2.9x5.1x2.6x
Price / LTM Sales
1.8x4.5x3.2x
Upside (Analyst Target)
-6.7%42.7%
Fair Value Upside
Unlock−5.6%5.8%Unlock

Earnings

Latest Release
May 12, 2025
EPS / Forecast
0.35 / --
Revenue / Forecast
4.70B / --
EPS Revisions
Last 90 days

MORL Income Statement

People Also Watch

400.20
BAJE
-0.72%
143.38
UNBK
+0.31%
72.98
NMDC
+1.16%
19.90
YESB
-0.45%
716.15
TATE
+0.08%

FAQ

What Stock Exchange Does Morepen Laboratories Ltd Trade On?

Morepen Laboratories Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Morepen Laboratories Ltd?

The stock symbol for Morepen Laboratories Ltd is "MORL."

What Is the Morepen Laboratories Ltd Market Cap?

As of today, Morepen Laboratories Ltd market cap is 33.67B.

What Is Morepen Laboratories Ltd's Earnings Per Share (TTM)?

The Morepen Laboratories Ltd EPS (TTM) is 2.20.

From a Technical Analysis Perspective, Is MORL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Morepen Laboratories Ltd Stock Split?

Morepen Laboratories Ltd has split 0 times.

How Many Employees Does Morepen Laboratories Ltd Have?

Morepen Laboratories Ltd has 2152 employees.

What is the current trading status of Morepen Laboratories Ltd (MORL)?

As of 23 Jul 2025, Morepen Laboratories Ltd (MORL) is trading at a price of 61.69, with a previous close of 61.54. The stock has fluctuated within a day range of 60.98 to 62.11, while its 52-week range spans from 41.66 to 100.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.